Literature DB >> 27315754

Optimisation for assay of fluorescein diacetate hydrolytic activity as a sensitive tool to evaluate impacts of pollutants and nutrients on microbial activity in coastal sediments.

Shan Jiang1, Jing Huang1, Haoliang Lu1, JingChun Liu1, Chongling Yan2.   

Abstract

Fluorescein diacetate (FDA) assay has been widely applied in coastal research to quantify microbial activity in sediments. However, the present FDA assay procedures embodied in sediment studies potentially include operational errors since the protocol was established for studies of terrestrial soil. In the present study, we optimised the procedure of FDA assay using sandy and cohesive sediments to improve experiential sensitivity and reproducibility. The optimised method describes quantitative measurement of the fluorescein produced when 1.0g of fresh sediment is incubated with 50mM phosphate buffer solution (pH: 7.3) and glass beads (2g) at 35°C for 1h under a rotation of 50rpm. The covariation coefficient of the optimised method ranged from 1.9% to 3.8% and the method sensitivity ranged from 0.25 to 1.57. The improved protocol provides a more reliable measurement of the FDA hydrolysis rate over a wide range of sediments compared to the original method.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Coastal sediment; Enzyme assay; Fluorescein diacetate; Microbial activity; Optimisation

Mesh:

Substances:

Year:  2016        PMID: 27315754     DOI: 10.1016/j.marpolbul.2016.06.031

Source DB:  PubMed          Journal:  Mar Pollut Bull        ISSN: 0025-326X            Impact factor:   5.553


  1 in total

1.  Biomonitoring and assessment of toxic element contamination in floodplain sediments and soils using fluorescein diacetate (FDA) enzymatic activity measurements: evaluation of possibilities and limitations through the case study of the Drava River floodplain.

Authors:  Péter Szabó; Gyozo Jordan; Tamás Kocsis; Katalin Posta; Levente Kardos; Robert Šajn; Jasminka Alijagić
Journal:  Environ Monit Assess       Date:  2022-08-03       Impact factor: 3.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.